converting between glp-1 agonists Strategies to Enhance the Therapeutic Efficacy of GLP‐1 Receptor through Structural Modification and Carrier Delivery - Zhang - 2025 - ChemBioChem Glucagon-like peptide-1 receptor: mechanisms and

Am J Physiol Endocrinol Metab 296: E473E479

Muscle is not cosmetic tissue

Despite the small sample size (only 10 patients), the observed benefits suggest that GLP-1RAs could have a therapeutic role in PsA through inflammation reduction, similar to what had been observed in PsO (61)

There was a statistically significant reduction in the primary endpoint, which was a composite of cardiovascular death or worsening HF events, with an RRR of 33%

JAMA 324:879887 [DOI] [PubMed] [Google Scholar] 5.Courcoulas AP, Patti ME, Hu B, Arterburn DE, Simonson DC, Gourash WF et al (2024) Long-term outcomes of medical management vs bariatric surgery in type 2 diabetes

518 Studies indicate that liraglutide may inhibit liver carcinogenesis through its metabolic effects, suggesting that GLP-1RAs could potentially play a role in preventing or managing HCC in the context of NASH